Publisert 18.08.2016

Regenics publish data on vehicle for Vernex® at Drug Delivery meeting, France

Regenics publish data on its carrier/vehicle GMO to be used in the CE marking device for wound healing, 4th Congress of Drug Delivery, France. September 25-28, 2016

At the 4th Congress on Innovation in Drug Delivery in Antibes, Regenics publish data on its carrier/vehicle GMO to be used in the CE marking device for wound healing. The device is under development for CE-marking mid 2018 with partner SP Technical Institute, Sweden.

Poster 4th Congress on Innovation in Drug Delivery 

Abstract 4th Congress on Innovation in Drug Delivery 

Info 4th Congress on Innovation in Drug Delivery, Sept 25-28, Antibes, France

 

 

Regenics is supported by:

Regenics AS has developed a number of assays and techniques to study effects of various substances on skin cells both in vitroin vivo and in the clinic. Our focus is to develop products and techniques for therapeutic skin applications and to improve skin appearance.